Certara (NASDAQ:CERT) Updates FY 2025 Earnings Guidance

Key Points

• Certara updated its FY 2025 earnings guidance, projecting earnings per share between $0.420 and $0.460, which is lower than the consensus estimate of $0.464.
• The company also issued revenue guidance of $415 million to $425 million, slightly below the consensus estimate of $421.1 million.
• Recent brokerages' ratings for Certara show mixed opinions, with UBS lowering its target price to $15.00 while Barclays raised it to $14.00, indicating varying levels of confidence in the stock.

Certara (NASDAQ:CERT - Get Free Report) updated its FY 2025 earnings guidance on Thursday. The company provided earnings per share guidance of 0.420-0.46 for the period, compared to the consensus earnings per share estimate of 0.464. The company issued revenue guidance of $415.0 million-$425.0 million, compared to the consensus revenue estimate of $421.1 million.

Wall Street Analyst Weigh In

Several brokerages have recently weighed in on CERT. UBS Group lowered their target price on Certara from $17.50 to $15.00 and set a "buy" rating on the stock in a report on Thursday. Barclays raised Certara from an "equal weight" rating to an "overweight" rating and increased their target price for the company from $11.00 to $14.00 in a report on Thursday, May 8th. JMP Securities reissued a "market perform" rating on shares of Certara in a report on Tuesday, May 6th. Morgan Stanley assumed coverage on Certara in a research report on Thursday, July 3rd. They set an "equal weight" rating and a $16.00 target price on the stock. Finally, KeyCorp lowered their target price on shares of Certara from $18.00 to $15.00 and set an "overweight" rating for the company in a research note on Monday, July 14th. Four investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $15.14.

Certara Price Performance

Certara stock traded up $1.64 during trading hours on Thursday, reaching $11.17. 2,096,565 shares of the stock were exchanged, compared to its average volume of 1,733,646. The company has a market cap of $1.81 billion, a P/E ratio of -558.95 and a beta of 1.42. The company has a current ratio of 2.78, a quick ratio of 2.78 and a debt-to-equity ratio of 0.27. Certara has a twelve month low of $8.64 and a twelve month high of $15.69. The stock has a 50 day moving average of $10.94 and a two-hundred day moving average of $11.79.

Certara (NASDAQ:CERT - Get Free Report) last issued its quarterly earnings data on Wednesday, August 6th. The company reported $0.07 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.10 by ($0.03). Certara had a negative net margin of 0.67% and a positive return on equity of 5.05%. The business had revenue of $104.57 million during the quarter, compared to the consensus estimate of $104.14 million. During the same quarter last year, the business earned $0.07 EPS. The firm's quarterly revenue was up 12.1% compared to the same quarter last year. Equities analysts expect that Certara will post 0.28 EPS for the current fiscal year.

Institutional Trading of Certara

Institutional investors and hedge funds have recently bought and sold shares of the company. AQR Capital Management LLC purchased a new position in shares of Certara in the first quarter worth approximately $259,000. Goldman Sachs Group Inc. raised its stake in Certara by 65.6% during the first quarter. Goldman Sachs Group Inc. now owns 228,996 shares of the company's stock valued at $2,267,000 after purchasing an additional 90,724 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in Certara by 13.6% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 299,528 shares of the company's stock valued at $2,965,000 after acquiring an additional 35,954 shares during the last quarter. Finally, Jane Street Group LLC lifted its stake in Certara by 17.1% in the first quarter. Jane Street Group LLC now owns 277,054 shares of the company's stock worth $2,743,000 after acquiring an additional 40,463 shares during the period. 73.96% of the stock is currently owned by institutional investors.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.